Clinical review report (Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PEX) and immunosuppress
Main Author: | |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | Inglés |
Published: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health
[2020]
|
Subjects: | |
See on Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009632229006719 |